The 2017 McDonald criteria continue to apply primarily to patients experiencing a typical clinically isolated syndrome, define what is needed to fulfil dissemination in time and space of lesions in the CNS, and stress the need for no better explanation for the presentation. Continue reading “The 2017 McDonald Criteria for Diagnosis of Multiple Sclerosis (MS)”
This International Myeloma Working Group consensus updates the disease definition of multiple myeloma to include validated biomarkers in addition to existing requirements of attributable CRAB features (hypercalcaemia, renal failure, anaemia, and bone lesions).
Continue reading “Revised IMWG Diagnostic Criteria for Multiple Myeloma”
The Expanded Disability Status Scale (EDSS), an accepted method of quantifying disability in Multiple Sclerosis (MS) consists of an eight-function system scale monitoring motor, sensory, cerebellar, brain stem, visual, bowel and bladder, pyramidal and other functions.
Continue reading “Kurtzke’s Expanded Disability Status Scale (EDSS)”
Multiple systems organ failure is said present when more than one of the system dysfunctions detected by test values exceeding the threshold values.
Continue reading “Knaus Criteria for Multiple System Organ Failure (MSOF)”
The multiple endocrine neoplasia (MEN) syndromes are rare autosomal-dominant conditions that predispose affected individuals to benign and malignant tumors of the pituitary, thyroid, parathyroids, adrenals, endocrine pancreas, paraganglia, or nonendocrine organs.
Continue reading “Diagnosis of Multiple Endocrine Neoplasia Syndromes”